Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-resolution photogrammetry reveals links between reef structural complexity, fish communities, and human influence in a remote Pacific atoll.

The Science of the total environment·2026
Same author

Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing.

Haematologica·2026
Same author

Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.

Blood advances·2026
Same author

Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK.

HemaSphere·2026
Same author

High-grade B-cell lymphomas: high difficulties to diagnose and treat?

Hematology. American Society of Hematology. Education Program·2025
Same author

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Related Experiment Video

Updated: Jun 27, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Primary mediastinal B-cell lymphoma.

Peter W M Johnson1, Andrew J Davies

  • 1Cancer Research UK Clinical Centre, University of Southampton, School of Medicine, Southampton General Hospital, Southampton, UK. johnsonp@southampton.ac.uk

Hematology. American Society of Hematology. Education Program
|December 17, 2008
PubMed
Summary
This summary is machine-generated.

Primary mediastinal B-cell lymphoma is a distinct entity. Research suggests it may benefit from specific chemotherapy regimens, potentially reducing the need for radiotherapy, with ongoing trials exploring advanced imaging for treatment de-escalation.

Related Experiment Videos

Last Updated: Jun 27, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Primary mediastinal B-cell lymphoma (PMBCL) is recognized as a unique clinicopathologic entity.
  • Molecular data confirms PMBCL's distinction from other large B-cell lymphomas.
  • Retrospective studies indicate potential differential responses to chemotherapy regimens.

Purpose of the Study:

  • To evaluate the efficacy of different chemotherapy regimens in treating PMBCL.
  • To assess the impact of rituximab on treatment outcomes in PMBCL.
  • To explore the role of FDG-PET scanning in prognostic assessment and treatment de-escalation for PMBCL.

Main Methods:

  • Retrospective analysis of treatment responses.
  • Molecular characterization of primary mediastinal B-cell lymphoma.
  • Prospective examination of FDG-PET scanning's prognostic value.
  • International collaborative clinical trials, including IELSG 26.

Main Results:

  • PMBCL may respond better to certain multi-agent chemotherapy regimens compared to standard CHOP.
  • Rituximab addition may reduce observed differences in treatment response and the need for consolidation radiotherapy.
  • FDG-PET scanning shows promise for prognostic information, potentially enabling treatment de-escalation.

Conclusions:

  • PMBCL requires tailored treatment strategies, potentially differing from other large B-cell lymphomas.
  • Rituximab and advanced imaging like FDG-PET may refine PMBCL management.
  • International collaboration is crucial for advancing PMBCL research due to its rarity.